Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled study of LH-1801 tablets in Chinese adults with type 2 diabetes mellitus inadequately controlled with diet and exercise alone
CTR20240399Phase 3Completed
- Sponsor
- Jiangsu Lianhuan Pharmaceutical Co., Ltd.
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of LH-1801 in type 2 diabetes mellitus (T2DM), sponsored by Jiangsu Lianhuan Pharmaceutical Co., Ltd.. Started Jun 2024; status: completed.
02
Drugs
LH-1801
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20240399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240399.